Zomedica Pharmaceuticals Corp. (ZOM.V) (CVE:ZOM – Get Free Report) fell 6.6% on Monday . The company traded as low as C$0.29 and last traded at C$0.29. 4,800 shares changed hands during trading, an increase of 68% from the average session volume of 2,858 shares. The stock had previously closed at C$0.31.
Zomedica Pharmaceuticals Corp. (ZOM.V) Price Performance
The company has a quick ratio of 15.25, a current ratio of 15.31 and a debt-to-equity ratio of 4.91. The firm has a market cap of C$36.73 million and a P/E ratio of -2.61. The business’s 50 day moving average is C$0.29 and its two-hundred day moving average is C$0.28.
About Zomedica Pharmaceuticals Corp. (ZOM.V)
Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies.
Featured Stories
- Five stocks we like better than Zomedica Pharmaceuticals Corp. (ZOM.V)
- Consumer Discretionary Stocks Explained
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- What is a Death Cross in Stocks?
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- How to invest in marijuana stocks in 7 stepsĀ
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Zomedica Pharmaceuticals Corp. (ZOM.V) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zomedica Pharmaceuticals Corp. (ZOM.V) and related companies with MarketBeat.com's FREE daily email newsletter.